Shenzhen Salubris Pharmaceuticals Co., Ltd. (SHE: 002294)
China flag China · Delayed Price · Currency is CNY
30.93
-0.25 (-0.80%)
Nov 15, 2024, 3:04 PM CST

Shenzhen Salubris Pharmaceuticals Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
34,48135,64436,22530,22029,13820,858
Upgrade
Market Cap Growth
16.90%-1.61%19.87%3.71%39.70%-4.55%
Upgrade
Enterprise Value
32,68833,89833,15427,01728,49420,363
Upgrade
Last Close Price
30.9332.0831.8125.9726.9318.47
Upgrade
PE Ratio
56.2761.6854.8551.93448.7727.16
Upgrade
PS Ratio
8.7910.5910.409.8810.644.67
Upgrade
PB Ratio
4.014.424.543.765.213.13
Upgrade
P/FCF Ratio
61.44211.6197.4243.0239.8119.87
Upgrade
P/OCF Ratio
32.6542.4637.3125.5021.2013.84
Upgrade
EV/Sales Ratio
8.3610.079.528.8310.404.56
Upgrade
EV/EBITDA Ratio
34.2038.9337.9533.8451.5919.32
Upgrade
EV/EBIT Ratio
55.0362.4958.6253.5793.0324.70
Upgrade
EV/FCF Ratio
58.24201.2489.1638.4638.9319.40
Upgrade
Debt / Equity Ratio
0.010.010.030.010.070.05
Upgrade
Debt / EBITDA Ratio
0.080.070.240.100.710.33
Upgrade
Debt / FCF Ratio
0.140.380.560.110.530.33
Upgrade
Asset Turnover
0.400.350.370.380.370.57
Upgrade
Inventory Turnover
2.332.062.082.001.901.80
Upgrade
Quick Ratio
2.513.402.563.881.493.24
Upgrade
Current Ratio
3.724.062.944.351.943.97
Upgrade
Return on Equity (ROE)
7.42%7.25%7.92%7.75%0.82%10.07%
Upgrade
Return on Assets (ROA)
3.78%3.54%3.72%3.90%2.61%6.59%
Upgrade
Return on Capital (ROIC)
4.39%4.16%4.33%4.47%2.95%7.29%
Upgrade
Earnings Yield
1.78%1.63%1.76%1.77%0.21%3.43%
Upgrade
FCF Yield
1.63%0.47%1.03%2.32%2.51%5.03%
Upgrade
Dividend Yield
1.60%1.56%1.57%1.54%-2.71%
Upgrade
Payout Ratio
89.43%94.71%69.25%2.91%878.69%119.23%
Upgrade
Buyback Yield / Dilution
-0.23%-1.55%-2.90%-5.23%3.55%-0.26%
Upgrade
Total Shareholder Return
1.37%0.00%-1.33%-3.69%3.55%2.45%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.